Consumer goods powerhouse Reckitt Benckiser, the manufacturer behind globally recognized brands like Dettol and Durex, has issued a stark warning regarding the financial repercussions of sustained high oil prices linked to the ongoing Iran conflict. The company projects a potential cost impact soaring as high as £150 million should oil prices remain elevated throughout 2026.
Projected Financial Strain from Oil Market Volatility
The firm detailed that if crude oil prices persist at $110 per barrel, equivalent to approximately £81.33, for the entirety of 2026, the group could be burdened with additional costs ranging between £130 million and £150 million. This significant financial pressure stems directly from the geopolitical tensions in the Middle East, which have driven commodity prices upward.
Company's Strategy to Mitigate the Impact
Reckitt, which operates key manufacturing sites in Hull and Slough, has characterized this potential cost increase as a "manageable level." The company plans to offset these challenges through a combination of strategic measures, including enhancing supply chain flexibility and implementing calculated pricing adjustments across its product portfolio.
However, the implications extend beyond corporate finances. The group cautioned that persistently high commodity prices could dampen consumer demand. "While challenging to forecast, if commodity prices remain at significantly elevated levels throughout the year we would anticipate an impact on consumer demand as a result of pressure on household budgets," a company statement explained.
Market Reaction and Recent Financial Performance
The financial markets reacted swiftly to this news. Shares in the FTSE 100-listed conglomerate plummeted by more than 5% during early trading on Wednesday, reflecting investor concerns over the projected cost pressures and their potential effect on profitability.
In its latest financial update, Reckitt reported a modest first-quarter revenue increase of 0.6% on a like-for-like basis. This growth was primarily driven by strategic price hikes, which helped counterbalance a 2% decline in overall sales volumes. The company's core business, excluding its Mead Johnson Nutrition division, experienced a sharp deceleration in growth, slowing to 1.3% from 5.9% in the previous quarter.
Factors Influencing the Slower Growth
This slowdown was attributed to a confluence of challenging factors: a notably subdued global cold and flu season, difficult trading conditions across European markets, and ongoing supply chain disruptions directly stemming from the Middle East conflict. Despite these headwinds, Reckitt reaffirmed its commitment to its full-year guidance, anticipating like-for-like net sales growth between 4% and 5% for 2026.
Profit Margin Forecast and Future Outlook
The company did, however, issue a caution regarding profit margins, forecasting a decline in the first half of the year. This expected dip is partly a direct consequence of the financial strain imposed by the Iran conflict. Reckitt anticipates that a stronger performance in the latter half of 2026 will help offset these initial margin pressures.
Chief Executive Kris Licht expressed confidence in the company's strategic direction, stating, "We maintain our like-for-like net revenue guidance for 2026. This will be driven by sequential growth from our market-leading Powerbrands, as the season resets and we continue to launch superior innovations including Mucinex 12-hour Cold and Fever, improved performance in Europe and continued strong growth across China, India and non-seasonal North America."
The warning from Reckitt underscores the broader economic vulnerabilities faced by multinational corporations amid geopolitical instability, highlighting how regional conflicts can translate into tangible financial challenges for global businesses through mechanisms like commodity price inflation.
